empower pharmacy lawsuit semaglutide update Novo Nordisk expands legal action to protect US patients from unsafe, non-FDA-approved compounded "semaglutide" FDA Warns on Certain Forms

How exactly does this type of medication help people living with obesity

This means that insulin is released when blood sugar levels are higher, reducing the risk of hypoglycaemia (low blood sugar) unless other glucose-lowering medicines are being used in conjunction with Mounjaro

Continuous monitoring and follow-up

they are adjuncts, not substitutes

Patients should also be informed about the boxed warning regarding medullary thyroid carcinoma risk, the importance of avoiding these medications during pregnancy and lactation, and the need for appropriate monitoring if rapid improvements in blood glucose occur in patients with diabetes and retinopathy